📊 Score Breakdown
Offering Ability
80
Cash Runway
65
Float Risk
80
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
34%
💰 Capital Raise
53%
• Under 12 months cash (11mo)
• Active shelf registration ($500M, 65% of market cap)
📜 Warrant Exercise
15%
• Warrant overhang: 14.9% of shares outstanding
📉 Score Deterioration
15%
• Score already CRITICAL (76/100) — events likely imminent
💹 Market Data
Market Cap$766.18M
Shares Outstanding29.80M
Float10.29M
Cash$16.56M
Debt$9.17M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 68.0% shares (2025Q4 vs prior)
53 institutional holders · 6.70M shares
#1
Alyeska Investment Group, L.P.
2.42M shares
#2
AWM Investment Company, Inc.
2.15M shares
#3
VANGUARD GROUP INC
386.8K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest4.03M
Days to Cover1.2
% of Float39.2%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2025
424B5
ATM
Apr 27, 2026
8-K
8K EVENT
Apr 27, 2026
EFFECT
EFFECT
Apr 08, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for VELO
📊 VELO FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 VELO Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.